Amanote Research
Register
Sign In
KDM6A Loss Induces Aggressive Pancreatic Cancer in Mice
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2018-052
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
March 23, 2018
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Loss of KDM6A Characterizes a Poor Prognostic Subtype of Human Pancreatic Cancer and Potentiates HDAC Inhibitor Lethality
International Journal of Cancer
Cancer Research
Oncology
Acute Loss of TET Function Results in Aggressive Myeloid Cancer in Mice
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-Like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors
Cancer Cell
Cancer Research
Oncology
Cell Biology
YM155 Induces EGFR Suppression in Pancreatic Cancer Cells
PLoS ONE
Multidisciplinary
Weight Loss Precedes Cancer-Specific Symptoms in Pancreatic Cancer-Associated Diabetes Mellitus
Pancreas
Internal Medicine
Endocrinology
Hepatology
Metabolism
Diabetes
Casein Kinase II Inhibition Induces Apoptosis in Pancreatic Cancer Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Oral LPS Dosing Induces Local Immunological Changes in the Pancreatic Lymph Nodes in Mice
Journal of Diabetes Research
Endocrinology
Metabolism
Diabetes
FGF10/FGFR2 Signal Induces Cell Migration and Invasion in Pancreatic Cancer
British Journal of Cancer
Cancer Research
Oncology
Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice
Gastroenterology
Hepatology
Gastroenterology